The Allstate Co. (NYSE:ALL) Position Decreased by GW Henssler & Associates Ltd.

GW Henssler & Associates Ltd. trimmed its holdings in shares of The Allstate Co. (NYSE:ALL) by 1.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 185,223 shares of the insurance provider’s stock after selling 2,587 shares during the period. Allstate makes up 2.1% of GW Henssler & Associates Ltd.’s investment portfolio, making the stock its 8th largest position. GW Henssler & Associates Ltd.’s holdings in Allstate were worth $35,127,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. FSA Wealth Management LLC bought a new position in Allstate in the 3rd quarter worth approximately $26,000. Northwest Investment Counselors LLC bought a new stake in Allstate during the third quarter worth about $28,000. Catalyst Capital Advisors LLC purchased a new position in shares of Allstate during the 3rd quarter valued at about $29,000. Peoples Bank KS purchased a new stake in Allstate in the fourth quarter worth approximately $49,000. Finally, Transamerica Financial Advisors Inc. bought a new position in shares of Allstate during the 3rd quarter valued at $58,000. 76.47% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on ALL shares. Morgan Stanley upped their price target on shares of Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a research report on Thursday, November 7th. UBS Group upped their price target on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Keefe, Bruyette & Woods raised their price target on shares of Allstate from $235.00 to $243.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. Evercore ISI raised shares of Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Finally, BMO Capital Markets increased their target price on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $218.13.

Allstate Price Performance

Shares of ALL stock opened at $192.60 on Monday. The business’s fifty day moving average is $193.92 and its 200 day moving average is $188.46. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The stock has a market cap of $51.00 billion, a price-to-earnings ratio of 12.47, a PEG ratio of 1.45 and a beta of 0.52. The Allstate Co. has a twelve month low of $153.42 and a twelve month high of $209.88.

Allstate Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th were given a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date was Friday, November 29th. Allstate’s dividend payout ratio is presently 23.83%.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.